Big Pharma Snaps Up Local Cancer Biotech
As the sun begins to rise at the J. P. Morgan Healthcare Conference, there's a big announcement from GSK plc. They're swooping in to acquire IDRx, a small biotech company based in Plymouth, Massachusetts. IDRx is known for their work on personalized treatments for a rare cancer called gastrointestin